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The cell-death machine
Arul M. Chinnaiyan and Vishva M. Dixit
Apoptosis, or programmed cell death, is the physiological
process whereby individual cells are deliberately eliminated to
achieve homeostasis and proper metazoan development.
Numerous genes have recently been identified that are
involved in apoptosis: some are believed to encode death
effectors, whereas others encode positive or negative
regulators of the cell-death machine. Precisely how these
various proteins interact in the molecular mechanism of
apoptosis remains to be discovered.
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Introduction
In the multicellular organism, genetically regulated mech-
anisms determine not only which cells live, but also which
cells die [1]. In the adult, steady-state condition, cell divi-
sion must be counterbalanced by cell death. This physio-
logically important cell death is an active process, known
as programmed cell death, or apoptosis. Apoptosis is char-
acterized by profound morphological alterations of the cell
and, specifically, the nucleus. Typically, apoptotic
changes include cellular shrinkage, membrane blebbing
and chromatin condensation [2]. The nuclear DNA of
apoptotic cells is often fragmented into oligonucleosomal-
sized units [3]. By contrast, ‘accidental’ cell death, or
necrosis, is caused by an overwhelming injury resulting in
cellular swelling and loss of membrane integrity [4].
Cell proliferation has been studied extensively, but genes
regulating cell death have only recently attracted the
attention of the biomedical research community. Perturba-
tions of apoptosis contribute to the pathogenesis of several
human diseases including cancer, acquired immuno-
deficiency syndrome and neurodegenerative disorders [5].
Thus, discovering ways to modulate apoptosis may have
immense therapeutic potential. The fundamental impor-
tance of the cell-death pathway is further emphasized by
its conservation throughout evolution [6]. In fact, genetic
studies of two invertebrates, Caenorhabditis elegans and
Drosophila melanogaster, have provided the most insight
into the genes controlling apoptosis [7]. In this review, we
focus on the effectors, inhibitors and activators of the cell-
death pathway, and how they may function as a fine-tuned
cell-suicide machine. We shall not discuss certain impor-
tant regulators of apoptosis, such as p53, Rb and c-Myc,
which have been covered in other recent reviews [8,9].
The engine of cell death
It is becoming apparent that proteases play an important
part in the apoptotic mechanism [10]. Protease inhibitors
of various specificities have been shown to inhibit cell
death [11]. Furthermore, granzyme B, an aspartate-specific
serine protease, is an important component of cytotoxic T-
cell-mediated apoptosis [12,13]. Purified granzyme B, in
combination with perforin, a pore-forming protein, induces
rapid apoptosis of various target cell lines [14].
Systematic genetic studies of C. elegans have provided more
direct evidence that proteases comprise the effector arm of
the cell death pathway. Two genes, ced-3 and ced-4, are
required for all somatic cell deaths that occur during nema-
tode development [15]. Mutations of ced-3 and ced-4 abolish
the apoptotic capability of cells that would otherwise be
destined to die during C. elegans embryogenesis [16]. No
homologs of the CED-4 protein have yet been identified,
but numerous relatives of CED-3 have been characterized
and comprise a new family of cysteine proteases. 
The first mammalian homolog of CED-3 identified was
interleukin-1b (IL-1b) converting enzyme (ICE), a cys-
teine protease responsible for the processing of pro-IL-1b
to the active cytokine [17]. Like granzyme B, ICE has the
unusual property of cleaving after aspartate residues [18].
Overexpression of ICE or CED-3 in Rat-1 fibroblasts
induces apoptosis, suggesting that ICE is functionally, as
well as structurally, related to CED-3 [19]. However, such
evidence is not conclusive, as ectopic expression of a
number of proteases including chymotrypsin, proteinase K
and trypsin cause significant apoptosis [20].
Subsequent studies have suggested that proteases related
to ICE might be more important than ICE itself in the
apoptotic mechanism. First, a number of cell types stably
secrete mature IL-1b without undergoing apoptosis.
Second, ICE-deficient mice, although unable to generate
active IL-1b, do not have any obvious defects in apoptosis,
except possibly in the apoptotic pathway induced by
engagement of the cell-surface receptor Fas/APO-1
[21,22]. Third, in an in vitro model of apoptosis, extracts
prepared from chicken DU249 cells failed to cleave the
primary substrate of ICE, pro-IL-1b [23]; instead, a proteo-
lytic activity in these extracts, termed prICE, cleaved the
well-characterized ‘death substrate’ poly (ADP-ribose)
polymerase (PARP) into fragments characteristic of apop-
tosis [23]. Purified ICE failed to cleave PARP [23,24],
suggesting that prICE is distinct from ICE.
To date, six mammalian homologs of CED-3 and ICE
have been characterized, including Nedd-2/ICH1 [25,26],
Yama/CPP32/apopain [24,27,28], Tx/ICH2/ICE rel-II
[29–31], ICE rel-III [29], Mch2 [32], and ICE-LAP3/
Mch3/CMH-1 [33–35]. On the basis of searches of the
‘expressed sequence tagged’ (EST) database of sequences
from expressed human genes (C. Vincenz, H. Duan,
V.M.D., unpublished observation), there are at least three
additional mammalian ICE/CED-3 homologs. Three sub-
families of the ICE/CED-3 family have been defined (Fig.
1): Yama, ICE-LAP3, and Mch2 are closely related to C.
elegans CED-3 and comprise the CED-3 subfamily; ICE,
ICE rel II and ICE rel III form the ICE subfamily; and
ICH1 and its mouse homologue, NEDD-2, form the
NEDD-2 subfamily. All family members so far character-
ized contain an active site QACRG pentapeptide and are
expressed in a broad range of tissues, developmental stages
and cell lines. Ectopic expression of these ICE/CED-3
homologs in a variety of cells causes apoptosis.
An important advance came with the discovery that Yama,
unlike ICE, efficiently cleaves the death substrate PARP
into fragments characteristic of apoptosis [24,28]. Acti-
vated Yama was biochemically purified from THP-1 cells
using the Ac-DEVD-CHO tetrapeptide aldehyde corres-
ponding to the amino acids of the PARP cleavage site [28].
This peptide was used to remove active Yama, and pre-
sumably other Yama-like proteases, from apoptotic
osteosarcoma cell extracts, abrogating their apoptotic
potential in vitro. This apoptotic activity could be restored
by adding back purified Yama to the depleted extracts
[28]. Taken together, these observations suggest that
Yama may be the physiological PARP-cleaving enzyme
(prICE), and may serve as the mammalian equivalent of
CED-3.
Soon after these results on Yama came the discovery that
Mch2 and ICE-LAP3 also cleave PARP efficiently
[32,34,35]. Interestingly, both proteases are in the same
subfamily — the CED-3 subfamily — as Yama (Fig. 1).
Furthermore, ICE-LAP3 is inhibited by the Ac-DEVD-
CHO tetrapeptide aldehyde with similar kinetics to those
shown by Yama [34,35]. Thus, the PARP-cleavage activity
of apoptotic cells (prICE) may actually be carried out by
more than one ICE-like protease, suggesting redundancy
in the cell-death pathway. As expected, CED-3 was
shown to function as a cysteine protease [36,37]. Like
Yama and ICE-LAP3, CED-3 cleaves PARP more
efficiently than it cleaves pro-IL-1b, and it is also
inhibited by Ac-DEVD-CHO [37].
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Figure 1
Phylogenetic analysis of the ICE/CED-3 family of cysteine proteases,
which can be subdivided into three groups. Sequences were aligned
using the DNASTAR Align program.
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If members of the ICE/CED-3 family are involved in the
cell-death pathway, they should be activated by apoptotic
death stimuli. Like the family prototype, ICE, other
members of the ICE/CED-3 family are synthesized as
proenzymes which are proteolytically processed to form
active heterodimeric enzymes [18]. Yama is expressed as a
32 kDa precursor, and upon activation it is processed into
p17 and p12 subunits [28]. As predicted, Yama is activated
upon receipt of various apoptotic stimuli, such as engage-
ment of the Fas/APO-1 receptor [38,39], or treatment with
the broad-spectrum protein kinase inhibitor staurosporine
[38]. Furthermore, granzyme B can directly activate Yama,
suggesting a potential mechanism for cytotoxic T-cell-
induced apoptosis [40,41]. Like Yama, ICE-LAP3 and
Mch2 are activated by a variety of apoptotic stimuli
([33,38] and K. Orth, personal communication), implying
that the ICE-like proteases most related to CED-3 (Fig. 1)
are important components of the cell-death machinery
(Fig. 2). Thus, mammals, unlike the nematode, may
possess an arsenal of CED-3-like proteases able to trans-
mit the death signal. These apoptotic proteases may each
cleave a specific ‘death substrate’, form redundant path-
ways or comprise a proteolytic cascade.
Given that mammalian CED-3 homologs are apoptotic
effectors, what are their substrates? Importantly, which
substrates must be cleaved to drive cells into apoptosis? As
discussed earlier, PARP, one of the best-characterized
death substrates, is cleaved during many, if not all, forms
of apoptosis [24,42]. Cleavage of PARP is probably not
directly important in the cell-death mechanism, as PARP-
deficient mice develop normally and do not show signifi-
cant perturbations of apoptosis [43]. The list of death
substrates and potential targets for ICE-like proteases is
growing and includes the nuclear lamins [44,45], the
70 kDa component of U1 small nuclear ribonucleoprotein
(U1-70 kDa snRNP) [46,47], D4 guanine nucleotide dis-
sociation inhibitor (D4-GDI) [48], sterol regulatory
element binding proteins (SREBPs) [49] and protein
kinase C d (PKCd) [50]. It is not yet clear whether the
cleavage of any of these substrates is important in the
execution phase of apoptosis. 
As mentioned, profound morphological alterations of the
nucleus are a hallmark of apoptosis, and ICE-like pro-
teases may have an important role here. The nuclear
lamins are cleaved early during apoptosis [45]. Lamins are
intermediate filament proteins that provide a structural
framework for the inner nuclear membrane. Recent
studies suggest that an ICE-like enzyme distinct from
Yama/CPP32 may be responsible for lamin proteolysis
[44]. Incubation with the ICE inhibitor YVAD
chloromethyl ketone blocked lamin cleavage, PARP
cleavage and DNA fragmentation in nuclei added to apop-
totic cell extracts. Interestingly, only lamin cleavage was
susceptible to inhibition by tosyl-L-lysl chloromethyl
ketone (TLCK) [44]. This selective inhibition also par-
tially blocked the morphologic transformation of added
nuclei [44]. These observations provide further evidence
for the involvement of multiple ICE/CED-3 family
members in the apoptotic mechanism (Fig. 2).
What is the subcellular localization of ICE/CED-3 family
members? Enucleated cells treated with various death
stimuli undergo the morphological changes associated
with apoptosis, suggesting the cell-death machinery
resides outside the nucleus [51,52]. Indeed, pro-Yama and
pro-ICE-LAP3 have been localized to the cell cytoplasm
([33] and our unpublished observation). By contrast, active
ICE localizes to the external surfaces of the plasma mem-
brane, further emphasizing the role of ICE in IL-1b pro-
cessing and secretion rather than apoptosis [53]. But if the
cell-death machinery is cytoplasmic, it is unclear how it
gains access to the nucleus to initiate DNA fragmentation,
chromatin condensation and the cleavage of several
nuclear death substrates, including PARP, U1-70 kDa and
the nuclear lamins. Interestingly, active granzyme B has
been localized to the nucleus [54]. It will be important to
Review  Regulation of cell death  557
Figure 2
The cell-death machinery. Apoptotic stimuli lead to the processing of
CED-3-like apoptotic proteases, generating their active, heterodimeric
forms. The consequences of protease activation are also shown.
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determine whether the processed, active apoptotic pro-
teases have access to the nucleus.
Braking cell death
The C. elegans model system has also provided insight into
the negative regulators of the cell-death pathway (Table
1). The ced-9 gene antagonizes the function of ced-3 and
ced-4 by blocking cell death [55]. Importantly, CED-9 is
homologous to Bcl-2, the prototypic member of a growing
family of cell-death regulators [56]. First identified for its
role in B-cell malignancies, bcl-2 when overexpressed
inhibits cell death induced by a variety of apoptotic
stimuli and in numerous cell types [57]. The fact that bcl-2
can substitute functionally for ced-9, preventing cell death
in the nematode, further emphasizes the highly conserved
nature of the cell-death machinery [56].
The Bcl-2 family is comprised of both inhibitors of cell
death, such as Bcl-2 and Bcl-xL, and promoters of cell
death, such as Bax and Bak [9,58,59]. The question of how
the negative regulators Bcl-2 and Bcl-xL function relative to
the death-promoting members of the Bcl-2 family is a con-
troversial one. Importantly, Bcl-2 family members can form
homodimers and heterodimers [59,60]. It was originally
proposed that Bax (and presumably Bak) directly engages
the cell-death machinery, whereas Bcl-2 and Bcl-xL merely
antagonize this interaction [61]. Supporting this contention,
mutant forms of Bcl-2 that fail to heterodimerize with Bax
and Bak lose their ability to protect cells from apoptosis
[61]. Recently, however, Cheng et al. [62] have identified
mutant forms of Bcl-xL that fail to interact with Bax or Bak,
but still maintain death-inhibiting activity, arguing for the
existence of a Bax/Bak-independent cell-death pathway.
These recent findings would support a model in which Bax
and Bak promote cell death by sequestering Bcl-2 and
Bcl-xL, preventing these negative regulators from binding
and inhibiting their intended target.
Where do Bcl-2 and CED-9 function relative to members
of the CED-3 family? Genetic evidence in C. elegans sug-
gests that CED-9 functions upstream of the death effectors
CED-3 and CED-4, preventing their activation [63,64].
The molecular order of the cell-death pathway has been
confirmed biochemically in mammalian cells [38]. It was
demonstrated that Bcl-2 and Bcl-xL prevent the proteolytic
activation of the mammalian CED-3 homologs Yama, ICE-
LAP3 and Mch2 ([38], and A.M.C., unpublished data),
suggesting that Bcl-2/Bcl-xL function upstream of the
apoptotic proteases (Fig. 3). Molecular ordering of the cell-
death pathway will hopefully help explain how members
of the Bcl-2 family function.
Other negative regulators of cell death have been discov-
ered in the course of research on viruses. It is not surpris-
ing that viruses have mastered the art of keeping cells
alive, for it is in their interest to maintain the cell ‘factories’
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Figure 3
Regulation of the mammalian CED-3 homologs. The apoptotic activator
shown is a death-domain protein functionally related to Drosophila
Reaper, but it could also be considered a generic death signal.
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Table 1
Negative regulators of the cell-death pathway.
Protein Function
CED-9 Important inhibitor of cell death in C. elegans, 
homologous to Bcl-2 [55,56].
Bcl-2 family Some family members, such as Bcl-2 and Bcl-xL, 
inhibit cell death, whereas others, such as Bax and
Bak, promote cell death [9,58,59]
p35 Baculovirus protein that inhibits cell death in mammals, 
insects and nematodes. Its target is likely ICE/CED-3 
family members [36,81,83] 
CrmA (SPI-2) Cowpox serpin that inhibits ICE, ICE-like proteins and
granzyme B. Can block apoptosis induced by growth 
factor withdrawal [72], TNF [73], Fas [73–75], and 
poxvirus infection [71].
SPI-1 A poxvirus serpin likely having an enzyme specificity
distinct from CrmA; inhibits poxvirus-induced apoptosis 
[71].
IAP family Inhibitors of apoptosis; baculovirus, Drosophila and 
human homologs identified [82,85,86].
NAIP Inhibitor of cell death induced by various apoptotic
stimuli, including TNF; product of candidate gene
responsible for spinal muscular atrophy, and related
to IAPs [86,88].
Dad1 Protein that inhibits cell death; mammalian and
C. elegans homologs identified [110,111].
A20 Mammalian protein that inhibits TNF-induced apoptosis
but not Fas-induced apoptosis [112,113].
that produce their progeny. Viral counterparts of Bcl-2
include the adenovirus protein E1B-19 kDa [65,66] and
the Epstein Barr virus protein BHRF-1 [67]. Expression of
Bcl-2 or E1B-19 kDa inhibits Yama activation and apopto-
sis induced by E1A [68]. Proteins unrelated to Bcl-2 that
inhibit cell death and are harbored by viruses include
CrmA, p35 and the IAPs.
CrmA is a cowpox serpin that inhibits ICE-like proteases
and granzyme B [24,69,70]. However, ICE is inhibited by
CrmA at much lower concentrations than is Yama, ICE-
LAP3 or granzyme B [28,34]. CrmA blocks cell death
induced by viral infection [71], growth-factor withdrawal
[72], treatment with tumor necrosis factor (TNF) [73] and
engagement of Fas/APO-1 [73–75]. When CrmA-express-
ing cells are treated with anti-Fas antibody, both Yama
and ICE-LAP3 remain as inactive pre-enzymes, suggest-
ing that CrmA inhibits an ICE-like enzyme upstream of
Yama and ICE-LAP3 [38]. This hypothesis is especially
attractive considering that ICE has been shown to process
Yama into active subunits [24]. The role of ICE in the
Fas pathway is supported by the observation that thymo-
cytes from ICE-deficient mice are resistant to Fas-
induced cell death [22]. Significantly, however, ICE-
deficient mice do not exhibit the lymphoproliferative
phenotype [21,22] characteristic of mice that carrying a
defect in the fas gene [76]. We postulate that ICE, or
more likely a member of the ICE subfamily (Fig. 1), acts
as the CrmA target and functions upstream of Yama and
the Yama-related proteases (Fig. 2).
Baculovirus p35 is another viral inhibitor of apoptosis and
is remarkable in that it can block cell death in mammals,
insects and nematodes, suggesting that its target of action
is evolutionarily conserved [77–80]. Recent studies
suggest that p35 functions by directly inhibiting
ICE/CED-3 family members [36,81]. Although p35 is
specifically cleaved by ICE-like proteases, its mechanism
of action is unclear. Unlike CrmA, p35 is not related to the
serpin family of protease inhibitors. It is not yet known
whether one or more ICE/CED-3 family members are
targeted by p35 in mammalian cells.
The inhibitors of apoptosis — IAPs — constitute another
family of cell-death suppressors that have been abducted
by viruses [82,83]. Like p35, viral IAPs (from Orgyia
pseudotsugata and Cydia pomonella granulosis) block cell
death induced by baculovirus infection and other apop-
totic stimuli [82–84], but their mechanism of action is not
known. Recently, cellular homologs of the viral IAPs have
been identified in Drosophila and in mammals. In
Drosophila, DIAP1 was identified in a search for mutations
that enhance cell death triggered by the reaper gene (see
below), whereas DIAP2 was identified by a subsequent
Genbank search [85,86]. Transgenic flies expressing the
Drosophila IAPs are partially protected from cell death [85]. 
Mammalian homologs of the IAPs have recently been
identified by two groups. Rothe et al. [87] showed that
c-IAP1 and c-IAP2 are components of the tumor necrosis
factor receptor-2 (TNFR-2) signalling complex, which
includes two TNFR-associated factors (TRAF1 and
TRAF2). By searching the Genbank database, Liston et al.
[86] isolated the genes for the same IAPs, along with an
additional mammalian IAP family member, xIAP. Impor-
tantly, these mammalian IAPs inhibit cell death induced
by a number of apoptotic stimuli [86]. The baculoviral
inhibition of apoptosis protein repeat (BIR) domain,
which is the motif most conserved among species, likely
mediates the inhibition of cell death by the IAPs [82].
The gene encoding NAIP, a protein with homology to the
IAPs, was shown to be partially deleted in individuals with
spinal muscular atrophy (SMA), a common fatal autosomal
recessive disorder [88]. It has been postulated that SMA is
caused by inappropriate motor neuron apoptosis resulting
from the absence of a functional cell-death inhibitor. Con-
sistent with this hypothesis, overexpression of NAIP
inhibits apoptosis induced by a variety of stimuli [86]. The
human IAPs and NAIP are emerging as a new class of
endogenous mammalian cell-death suppressors, an area
previously monopolized by the Bcl-2 family. Future studies
will hopefully determine how the IAPs function relative to
the apoptotic proteases of the ICE/CED-3 family.
Igniting apoptosis
Studies of C. elegans have provided insights into the effec-
tors and the negative regulators — the ‘engine’ and
‘brakes’, respectively — of the cell-death machine.
Another invertebrate, Drosophila melanogaster, has been
useful in understanding how a dormant cell-death machine
may be activated [89]. Genetic analyses of Drosophila have
identified a gene, reaper, important in triggering the apop-
totic program [89]. The reaper gene encodes a 65-residue
polypeptide that is upregulated during Drosophila cell
death [89]. It is unlikely that reaper is a death effector, as
reaper-deficient embryos, although less sensitive to death
stimuli, still undergo apoptosis [90]. In addition, recent
studies suggest that reaper functions as an upstream activa-
tor of ICE/CED-3 homologs [80,91]. Transgenic flies
expressing reaper, under the control of an inducible pro-
moter, are protected from cell death by overexpression of
the baculovirus protein p35 [80,85], which is thought to
target ICE-like proteases. Furthermore, reaper-induced
death of Drosophila Schneider cells can be inhibited by the
broad-spectrum ICE-inhibitor, N-benzyloxycarbonyl-Val-
Ala-Asp-fluoromethylketone (z-VAD-FMK) [91]. Interest-
ingly, a Drosophila ICE/CED-3 homolog has recently been
identified in the Genbank database [7].
Although no mammalian equivalent of reaper has yet been
identified, Reaper shows weak homology to the so-called
‘death domain’ of certain mammalian proteins [92]. The
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death domain was first characterized as a region of homol-
ogy of about 70 amino acids in the 55 kDa TNFR-1 and
Fas/APO-1 [93,94]. TNFR-1 and Fas/APO-1 are type I
transmembrane proteins [95,96], and their activation is
caused by aggregation mediated by the respective ligands
or by agonist antibodies [97–99]. The death domains of
TNFR-1 and Fas/APO-1 are required for these receptors
to activate the apoptotic program [93,94]. The apoptotic
signal is thought to be transduced by clustering of death
domains [100]. Although reaper must be transcriptionally
up-regulated to signal death, subsequent oligomerization
may also play a role [89]. Like Reaper-induced cell death,
cell death induced by TNFR-1 and Fas/APO-1 is blocked
by p35 [101] and z-VAD-FMK (our unpublished observa-
tion), implicating ICE/CED-3 homologs in both death
pathways. An attractive hypothesis is that Fas/APO-1 and
TNFR-1 are chimeric molecules evolved from the linkage
of a Reaper-like motif to an extracellular domain, allowing
for direct activation of the cell-death machinery by
cytokines [92]. 
Reaper is also weakly homologous to FADD and TRADD,
the intracellular signaling molecules used by Fas/APO-1
and TNFR-1, respectively (reviewed in [102,103]).
Both FADD and TRADD contain death domains and,
on overexpression, they activate the death pathway
[104–106]. Endogenous FADD and TRADD associate
with their respective receptors in a ligand-dependent
fashion [107,108]. It has been postulated that TRADD
acts as an adaptor molecule that mediates the interaction
of TNFR-1 with FADD [107]. A dominant-negative
version of FADD blocks TNF- and Fas/APO-1-induced
apoptosis, suggesting that FADD acts as the common
conduit for cytokine-mediated cell death [107,109]. An
intriguing possibility is that, because of its similar
sequence, function, and cell autonomy, Reaper may repre-
sent an ancestral form of FADD and TRADD. One might
speculate that the dominant negative version of FADD
would block Reaper-induced cell death, suggesting that
the cell-death machine is activated or ‘ignited’ in a similar
way in mammals and Drosophila.
Conclusions
Identification of the genes that regulate cell death has pro-
pelled the study of apoptosis to the forefront of biomedical
research. Components of the cell-death pathway are likely
conserved through the evolution of multicellular organ-
isms. Invertebrate model systems have played an impor-
tant part in the identification of several cell-death genes,
but it is becoming apparent that the cell-death machinery
in mammals may be more complex because of redundancy.
For example, mammalian homologs of ced-9 include bcl-2,
bcl-xL, bax and bak. Similarly, a family of novel and diverse
cysteine proteases related to the death effector ced-3 have
been identified, a subset of which is likely to have an
important role in the apoptotic mechanism. The cell-death
machine is composed of a number of parts (or gene prod-
ucts), including activators, effectors and negative regula-
tors. Discovering how the individual components interact
is breathing new life into the study of cell death.
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